Skip to main content
. 2020 Oct 20;21(20):7767. doi: 10.3390/ijms21207767

Table A3.

Patient #3 laboratory findings.

Pt#3 ESR mm/h IS CRP mg/L WBC/μL HB g/dL PLT/μL IgG mg/dL IgA mg/dL
Before JAKinhibs 68 33.4 5.2 5320 12.5 357,000 1860 207
After JAKinhibs 60 32.0 2.4 10,220 11.4 318,000 1812 169
Last FUP 20 ND 12.0 ND ND ND ND ND